McKesson Corp (MCK)

MCK on New York Consolidated

200.80USD
28 Aug 2015
Change (% chg)

$2.21 (+1.11%)
Prev Close
$198.87
Open
$199.00
Day's High
$201.01
Day's Low
$198.01
Volume
1,896,429
Avg. Vol
1,241,528
52-wk High
$243.61
52-wk Low
$160.10

MCK

Chart for MCK

About

McKesson Corporation delivers pharmaceuticals, medical supplies and healthcare information technology. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and drugs and equipment and health and beauty care products throughout North America and internationally. This segment... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $46,666.57
Shares Outstanding(Mil.): 232.40
Dividend: 0.28
Yield (%): 0.56

Financials

  MCK Industry Sector
P/E (TTM): 24.30 22.82 38.90
EPS (TTM): 8.26 -- --
ROI: 9.67 10.43 77.35
ROE: 21.80 11.73 90.09
Search Stocks

Allergan CEO, fresh off one deal, sets sights on others

NEW YORK - Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger.

27 Jul 2015

UPDATE 1-Allergan CEO, fresh off one deal, sets sights on others

NEW YORK, July 27 - Allergan plc CEO Brent Saunders is ready to put the $36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger.

27 Jul 2015

McKesson settles investigation on controlled substances

- U.S. drug wholesaler McKesson Corp said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.

30 Apr 2015

McKesson settles investigation on controlled substances

April 30 - U.S. drug wholesaler McKesson Corp said it settled with several federal agencies, including the Department of Justice, claims alleging suspicious order reporting practices for controlled substances.

30 Apr 2015

Omnicare draws buyout interest from CVS, Express Scripts: Bloomberg

- Pharmacy service provider Omnicare Inc is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp , Bloomberg reported, citing people with knowledge of the matter.

30 Apr 2015

Omnicare draws buyout interest from CVS, Express Scripts - Bloomberg

April 30 - Pharmacy service provider Omnicare Inc is getting buyout interest from potential buyers, including Express Scripts Holding Co and CVS Health Corp, Bloomberg reported, citing people with knowledge of the matter.

30 Apr 2015

UPDATE 2-Higher prescription sales help Rite Aid beat profit estimates

April 8 - Rite Aid Corp reported a better-than-expected quarterly profit on Wednesday, and expected a renewed distribution agreement with McKesson Corp along with the remodeling of its wellness stores to benefit fiscal 2016 earnings.

08 Apr 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Validea
$12.00
Provider : New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks